Sellas Life Sciences Group Inc (SLS)
Net Income Growth
-45.51%
Quarterly · Period ending:
SLS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-45.51%period ending
Latest reported-45.51%period ending
SLS Quarterly Net Income YoY % (-242.43% → -45.51%)
Year-over-year change
High-resolution chart · PNG
SLS net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -45.5083% | |
| -44.6241% | |
| -13.6708% | |
| 4.4598% | |
| 11.6332% | |
| 39.2327% | |
| 17.1952% | |
| 23.2977% | |
| 15.4977% | |
| 13.7965% | |
| 10.7993% | |
| -31.9709% | |
| -5.063% | |
| 33.7255% | |
| -38.2389% | |
| 0.8892% | |
| -82.3976% | |
| -596.7957% | |
| -77.5565% | |
| -58.3948% | |
| -4.2486% | |
| 41.9986% | |
| 49.9124% | |
| -6.4493% | |
| -41.1934% | |
| 8.6842% | |
| 44.3143% | |
| -1,348.9655% | |
| 48.3009% | |
| 43.252% | |
| -62.9326% | |
| 95.2263% | |
| 27.8677% | |
| 31.7716% | |
| -48.2415% | |
| 12.325% | |
| -255.9473% | |
| 28.9517% | |
| 71.9687% | |
| 61.5611% | |
| 134.4125% | |
| -56.5246% | |
| -147.3353% | |
| -192.0136% | |
| 21.4683% | |
| -315.4968% | |
| 83.5962% | |
| 33.5307% | |
| -107.7837% | |
| 72.7106% | |
| -1,193.0152% | |
| -48.3309% | |
| -4,796.4286% | |
| 62.4692% | |
| -336.0604% | |
| -14.3562% | |
| 94.7789% | |
| -544.6498% | |
| 186.7832% | |
| -32.4063% | |
| -75.3386% | |
| 1.158% | |
| 70.218% | |
| -38.4332% | |
| 57.8626% | |
| 6.8329% | |
| -53.6616% | |
| 12.3533% | |
| -17.6702% | |
| -57.6342% | |
| -52.5353% | |
| -22.1943% | |
| 9.2667% | |
| -87.3938% | |
| -242.4282% |